Barrier Isolation

Baxter’s BioPharma Solutions is expanding its cytotoxic contract manufacturing facility in Halle (Westfalen), Germany, to meet client needs. Such efforts mark its third capacity expansion, further enhancing Halle’s complete range of resources to support early-phase drug formulation through commercial scale-up, introduction, and lifecycle management.